# Cue Biopharma, Inc.: filings

CUE · Nasdaq · CIK 1645460 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cue.md) · [Financials](/companies/cue/financials.md) · [Filings](/companies/cue/filings.md) · [Insiders](/companies/cue/insiders.md)

## Reports and events: 146 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 214, 8-K 82, 3 36, 10-Q 26, CORRESP 15, UPLOAD 15, 424B5 12, DEFA14A 12, SC 13G 12, DEF 14A 11, S-8 11, 10-K 9, EFFECT 9, SC 13G/A 8, S-3 7, 4/A 6, D 6, PRE 14A 6, S-1/A 6, 144 5, SCHEDULE 13G/A 5, 10-K/A 4, ARS 4, 424B3 3, 5 2, 8-K/A 2, CT ORDER 2, POS AM 2, S-1 2, 10-Q/A 1, 3/A 1, 424B1 1, 424B7 1, 8-A12B 1, CERT 1, D/A 1, FWP 1, POSASR 1, S-1MEF 1, S-3/A 1, S-3ASR 1, SC 13D 1, SC 13D/A 1, SCHEDULE 13D 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-21 | 12:00 ET | [8-K](/filings/0001193125-26-396094.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-396094 |
| 2026-08-21 | 20:55 ET | [SCHEDULE 13D](/filings/0001725092-26-000015.md) | Ownership report, active investor | 0001725092-26-000015 |
| 2026-08-14 | 20:01 ET | [10-Q](/filings/0001193125-26-352128.md) | Quarterly report, period 2026-06-30 | 0001193125-26-352128 |
| 2026-08-14 | 20:00 ET | [8-K](/filings/0001193125-26-352126.md) | 2.02 Results of operations | 0001193125-26-352126 |
| 2026-08-03 | 20:47 ET | [8-K](/filings/0001193125-26-330730.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-330730 |
| 2026-07-10 | 21:29 ET | [8-K](/filings/0001193125-26-301052.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-301052 |
| 2026-06-03 | 20:16 ET | [8-K](/filings/0001193125-26-255479.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-255479 |
| 2026-06-02 | 20:45 ET | [8-K](/filings/0001193125-26-253709.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001193125-26-253709 |
| 2026-05-21 | 12:51 ET | [DEF 14A](/filings/0001193125-26-233369.md) | Proxy statement, period 2026-06-01 | 0001193125-26-233369 |
| 2026-05-14 | 20:19 ET | [8-K](/filings/0001193125-26-224101.md) | 9.01 Financial statements and exhibits | 0001193125-26-224101 |
| 2026-05-14 | 20:18 ET | [10-Q](/filings/0001193125-26-224091.md) | Quarterly report, period 2026-03-31 | 0001193125-26-224091 |
| 2026-05-01 | 00:42 ET | [8-K](/filings/0001193125-26-198588.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-198588 |
| 2026-04-22 | 12:47 ET | [8-K](/filings/0001193125-26-168907.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws | 0001193125-26-168907 |
| 2026-04-13 | 20:00 ET | [8-K](/filings/0001193125-26-152826.md) | 5.07 Shareholder vote results | 0001193125-26-152826 |
| 2026-04-07 | 12:00 ET | [8-K](/filings/0001193125-26-144569.md) | 8.01 Other events | 0001193125-26-144569 |
| 2026-03-27 | 20:05 ET | [8-K](/filings/0001193125-26-128993.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-128993 |
| 2026-03-16 | 20:01 ET | [DEF 14A](/filings/0001193125-26-108301.md) | Proxy statement, period 2026-03-16 | 0001193125-26-108301 |
| 2026-03-16 | 20:00 ET | [8-K](/filings/0001193125-26-108292.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-108292 |
| 2026-03-16 | 20:00 ET | [10-K](/filings/0001193125-26-108287.md) | Annual report, period 2025-12-31 | 0001193125-26-108287 |
| 2026-02-18 | 21:00 ET | [8-K](/filings/0001193125-26-056983.md) | 8.01 Other events | 0001193125-26-056983 |
| 2026-02-12 | 13:00 ET | [8-K](/filings/0001193125-26-047717.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-047717 |
| 2025-12-19 | 21:22 ET | [8-K](/filings/0001193125-25-326925.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-326925 |
| 2025-11-24 | 13:08 ET | [8-K](/filings/0001193125-25-292093.md) | 7.01 Regulation FD disclosure | 0001193125-25-292093 |
| 2025-11-20 | 21:00 ET | [8-K](/filings/0001193125-25-289713.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-289713 |
| 2025-11-12 | 21:01 ET | [10-Q](/filings/0001193125-25-277466.md) | Quarterly report, period 2025-09-30 | 0001193125-25-277466 |
| 2025-11-12 | 21:00 ET | [8-K](/filings/0001193125-25-277468.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-277468 |
| 2025-11-06 | 13:03 ET | [8-K](/filings/0001193125-25-268135.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-268135 |
| 2025-09-29 | 20:00 ET | [8-K](/filings/0000950130-25-000140.md) | 5.02 Departure or appointment of officers or directors | 0000950130-25-000140 |
| 2025-08-12 | 20:00 ET | [10-Q](/filings/0000950170-25-107270.md) | Quarterly report, period 2025-06-30 | 0000950170-25-107270 |
| 2025-08-12 | 20:00 ET | [8-K](/filings/0000950170-25-107268.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-107268 |
| 2025-07-01 | 20:00 ET | [8-K](/filings/0000950170-25-092168.md) | 1.01 Entry into a material agreement | 0000950170-25-092168 |
| 2025-06-10 | 20:00 ET | [8-K](/filings/0000950170-25-084279.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-084279 |
| 2025-05-12 | 20:00 ET | [10-Q](/filings/0000950170-25-069125.md) | Quarterly report, period 2025-03-31 | 0000950170-25-069125 |
| 2025-05-12 | 20:00 ET | [8-K](/filings/0000950170-25-069124.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-069124 |
| 2025-04-25 | 20:00 ET | [DEF 14A](/filings/0000950170-25-058681.md) | Proxy statement, period 2025-06-03 | 0000950170-25-058681 |
| 2025-04-15 | 20:48 ET | [8-K](/filings/0001193125-25-081592.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-081592 |
| 2025-04-14 | 21:03 ET | [8-K](/filings/0001193125-25-080277.md) | 1.01 Entry into a material agreement | 0001193125-25-080277 |
| 2025-03-31 | 20:00 ET | [8-K](/filings/0000950170-25-047678.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-047678 |
| 2025-03-31 | 20:00 ET | [10-K](/filings/0000950170-25-047677.md) | Annual report, period 2024-12-31 | 0000950170-25-047677 |
| 2025-03-12 | 20:00 ET | [8-K](/filings/0000950170-25-037885.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-037885 |
| 2024-11-14 | 21:00 ET | [10-Q](/filings/0000950170-24-127005.md) | Quarterly report, period 2024-09-30 | 0000950170-24-127005 |
| 2024-11-14 | 21:00 ET | [8-K](/filings/0000950170-24-127004.md) | 2.02 Results of operations | 0000950170-24-127004 |
| 2024-10-08 | 20:00 ET | [8-K](/filings/0000950170-24-113520.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-113520 |
| 2024-10-04 | 20:00 ET | [8-K](/filings/0000950170-24-112887.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-24-112887 |
| 2024-09-27 | 20:17 ET | [8-K](/filings/0001193125-24-227977.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-227977 |
| 2024-09-10 | 20:00 ET | [DEF 14A](/filings/0000950170-24-105104.md) | Proxy statement, period 2024-10-08 | 0000950170-24-105104 |
| 2024-09-03 | 20:30 ET | [8-K](/filings/0000950170-24-102851.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-102851 |
| 2024-08-16 | 20:00 ET | [8-K](/filings/0000950170-24-098032.md) | 3.01 Delisting notice | 0000950170-24-098032 |
| 2024-08-14 | 20:00 ET | [10-Q](/filings/0000950170-24-096967.md) | Quarterly report, period 2024-06-30 | 0000950170-24-096967 |
| 2024-07-25 | 20:00 ET | [8-K](/filings/0000950170-24-086476.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-086476 |

Page 1 of 3. [Older](/companies/cue/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.